AMIODARONE HYDROCHLORIDE tablet

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

AMIODARONE HYDROCHLORIDE (UNII: 976728SY6Z) (AMIODARONE - UNII:N3RQ532IUT)

Available from:

State of Florida DOH Central Pharmacy

INN (International Name):

AMIODARONE HYDROCHLORIDE

Composition:

AMIODARONE HYDROCHLORIDE 200 mg

Administration route:

ORAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Because of its life-threatening side effects and the substantial management difficulties associated with its use (see WARNINGS below), amiodarone is indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated. - Recurrent ventricular fibrillation. - Recurrent hemodynamically unstable ventricular tachycardia. As is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of amiodarone hydrochloride tablets favorably affects survival. Amiodarone should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating recurrent life-threatening ventricular arrhythmias, and who have access to appropriate monitoring facilities, including in-hospital and ambulatory continuous electrocardiographic monitoring

Product summary:

Amiodarone Hydrochloride Tablets, 200 mg are white to off-white, round-shaped, flat beveled-edge, uncoated tablets with bisect on one side and other side is plain; one side of bisect is debossed with 'ZE' and other side is debossed with '65' and are supplied as follows:

Authorization status:

Abbreviated New Drug Application

Patient Information leaflet

                                State of Florida DOH Central Pharmacy
----------
Read the Medication Guide that comes with amiodarone hydrochloride
tablets before you start taking
them and each time you get a refill. There may be new information.
This Medication Guide does not take
the place of talking with your doctor about your medical condition or
your treatment.
WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT
AMIODARONE HYDROCHLORIDE TABLETS?
Amiodarone hydrochloride tablets can cause serious side effects that
can lead to death including:
•
lung damage
•
liver damage
•
worse heartbeat problems
•
thyroid problems
Call your doctor or get medical help right away if you have any
symptoms such as the following:
•
shortness of breath, wheezing, or any other trouble breathing;
coughing, chest pain, or spitting up
of blood
•
nausea or vomiting; passing brown or dark-colored urine; feel more
tired than usual; your skin and
whites of your eyes get yellow; or have stomach pain
•
heart pounding, skipping a beat, beating very fast or very slowly;
feel light-headed or faint
•
weakness, weight loss or weight gain, heat or cold intolerance, hair
thinning, sweating, changes in
your menses, swelling of your neck (goiter), nervousness,
irritability, restlessness, decreased
concentration, depression in the elderly, or tremor.
Because of these possible side effects, amiodarone hydrochloride
tablets should only be used in adults
with life-threatening heartbeat problems called ventricular
arrhythmias, for which other treatments did not
work or were not tolerated.
Amiodarone hydrochloride tablets can cause other serious side effects.
See "What are the possible or
reasonably likely side effects of Amiodarone Hydrochloride Tablets?"
for more information.
If you get serious side effects during treatment with amiodarone
hydrochloride tablets you may need to
stop amiodarone hydrochloride tablets, have your dose changed, or get
medical treatment. Talk with your
doctor before you stop taking amiodarone hydrochloride tablets.
You may still have 
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                AMIODARONE HYDROCHLORIDE - AMIODARONE HYDROCHLORIDE TABLET
STATE OF FLORIDA DOH CENTRAL PHARMACY
----------
AMIODARONE HYDROCHLORIDE TABLETS
DESCRIPTION
Amiodarone hydrochloride, USP is a member of a class of antiarrhythmic
drugs with predominantly
Class III (Vaughan Williams' classification) effects. Amiodarone is a
benzofuran derivative: 2-butyl-3-
benzofuranyl 4-[2-(diethylamino)-ethoxy]-3,5-diiodophenyl ketone
hydrochloride.
The structural formula is as follows:
Amiodarone hydrochloride is a white to cream-colored crystalline
powder. It is slightly soluble in
water, soluble in alcohol and freely soluble in chloroform. It
contains 37.3% iodine by weight.
Each amiodarone hydrochloride tablet intended for oral administration
contains 200 mg of amiodarone
hydrochloride. In addition each tablet contains the following inactive
ingredients: colloidal silicon
dioxide, corn starch, lactose monohydrate, magnesium stearate,
povidone and sodium starch glycolate.
CLINICAL PHARMACOLOGY
ELECTROPHYSIOLOGY/MECHANISMS OF ACTION:
In animals, amiodarone is effective in the prevention or suppression
of experimentally induced
arrhythmias. The antiarrhythmic effect of amiodarone may be due to at
least two major properties:
1. a prolongation of the myocardial cell-action potential duration and
refractory period and
2. noncompetitive α- and β-adrenergic inhibition.
Amiodarone prolongs the duration of the action potential of all
cardiac fibers while causing minimal
reduction of dV/dt (maximal upstroke velocity of the action
potential). The refractory period is
prolonged in all cardiac tissues. Amiodarone increases the cardiac
refractory period without
influencing resting membrane potential, except in automatic cells
where the slope of the prepotential is
reduced, generally reducing automaticity. These electrophysiologic
effects are reflected in a
decreased sinus rate of 15 to 20%, increased PR and QT intervals of
about 10%, the development of U-
waves, and changes in T-wave contour. These changes should not require
discontinuation o
                                
                                Read the complete document
                                
                            

Search alerts related to this product